Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands

Johannes J. M. Kwakman, G. Vink, J. H. Vestjens, L. V. Beerepoot, J. W. de Groot, R. L. Jansen, F. L. Opdam, H. Boot, G. J. Creemers, J. M. van Rooijen, M. Los, A. J. E. Vulink, H. Schut, E. van Meerten, A. Baars, P. Hamberg, E. Kapiteijn, D. W. Sommeijer, C. J. A. Punt, M. Koopman

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)482-489
Number of pages8
JournalInternational Journal of Clinical Oncology
Volume23
Issue number3
DOIs
Publication statusPublished - 1 Jun 2018

Keywords

  • Trifluridine/tipiracil
  • TAS-102
  • Metastatic colorectal cancer
  • Compassionate use
  • Feasibility
  • QUALITY-OF-LIFE
  • THYMIDINE PHOSPHORYLASE
  • PERFORMANCE STATUS
  • ANTITUMOR-ACTIVITY
  • NEUTROPENIA
  • PREDICTOR
  • SURVIVAL
  • EFFICACY
  • TRIAL

Cite this